The effectiveness and safety of Risankizumab in pediatric patients with medically refractory inflammatory bowel disease

Michael P. Duggan, Evangelos D. Katsanos, Hassan Hamandi
Journal of Pediatric Gastroenterology and Nutrition · Wiley · 2026-11-05 · DOI: 10.1002/jpn3.70534

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles